These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 498715)

  • 21. High-dose intravenous melphalan: a review.
    Samuels BL; Bitran JD
    J Clin Oncol; 1995 Jul; 13(7):1786-99. PubMed ID: 7602368
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Morphine kinetics in cancer patients.
    Säwe J; Dahlström B; Paalzow L; Rane A
    Clin Pharmacol Ther; 1981 Nov; 30(5):629-35. PubMed ID: 7297022
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative pharmacokinetics of chlorambucil and melphalan in man.
    Alberts DS; Chang SY; Chen HS; Larcom BJ; Evans TL
    Recent Results Cancer Res; 1980; 74():124-31. PubMed ID: 7444135
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetics of indomethacin.
    Alván G; Orme M; Bertilsson L; Ekstrand R; Palmér L
    Clin Pharmacol Ther; 1975 Sep; 18(3):364-73. PubMed ID: 1100305
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of systemic hyperthermia on melphalan pharmacokinetics in mice.
    Honess DJ; Donaldson J; Workman P; Bleehen NM
    Br J Cancer; 1985 Jan; 51(1):77-84. PubMed ID: 3966973
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Plasma pharmacokinetics of high-dose oral melphalan in patients treated with trialkylator chemotherapy and autologous bone marrow reinfusion.
    Choi KE; Ratain MJ; Williams SF; Golick JA; Beschorner JC; Fullem LJ; Bitran JD
    Cancer Res; 1989 Mar; 49(5):1318-21. PubMed ID: 2645050
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetics of bethanidine in hypertensive patients.
    Shen D; Gibaldi M; Israili A; Bellward G; Cunningham R; Throne M; Dayton P; McNay J
    Clin Pharmacol Ther; 1975 Mar; 17(3):363-73. PubMed ID: 1120401
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of the fed and fasting states on the absorption of melphalan in multiple myeloma.
    Bosanquet AG; Gilby ED
    Cancer Chemother Pharmacol; 1984; 12(3):183-6. PubMed ID: 6705135
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tocainide kinetics after intravenous and oral administration in healthy subjects and in patients with acute myocardial infarction.
    Graffner C; Conradson TB; Hofvendahl S; Rydén L
    Clin Pharmacol Ther; 1980 Jan; 27(1):64-71. PubMed ID: 7351118
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetics and disposition of the oxytocin receptor antagonist L-368,899 in rats and dogs.
    Thompson KL; Vincent SH; Miller RR; Colletti AE; Alvaro RF; Wallace MA; Feeney WP; Chiu SH
    Drug Metab Dispos; 1997 Oct; 25(10):1113-8. PubMed ID: 9321512
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetically guided dosing for intravenous melphalan: a pilot study in patients with advanced ovarian adenocarcinoma.
    Ploin DY; Tranchand B; Guastalla JP; Rebattu P; Chauvin F; Clavel M; Ardiet C
    Eur J Cancer; 1992; 28A(8-9):1311-5. PubMed ID: 1515240
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Single- and multiple-dose metronidazole kinetics.
    Jensen JC; Gugler R
    Clin Pharmacol Ther; 1983 Oct; 34(4):481-7. PubMed ID: 6617070
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Physiological disposition of verapamil in man.
    Schomerus M; Spiegelhalder B; Stieren B; Eichelbaum M
    Cardiovasc Res; 1976 Sep; 10(5):605-12. PubMed ID: 971476
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Absolute oral bioavailability of traxoprodil in cytochrome P450 2D6 extensive and poor metabolisers.
    Taylor TJ; Diringer K; Russell T; Venkatakrishnan K; Wilner K; Crownover PH; Benincosa LJ; Gibbs MA
    Clin Pharmacokinet; 2006; 45(10):989-1001. PubMed ID: 16984212
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Absolute quinidine bioavailability.
    Ueda CT; Williamson BJ; Dzindzio BS
    Clin Pharmacol Ther; 1976 Sep; 20(3):260-5. PubMed ID: 954347
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Disposition of the angiotensin II receptor antagonist L-158,809 in rats and rhesus monkeys.
    Colletti AE; Krieter PA
    Drug Metab Dispos; 1994; 22(2):183-8. PubMed ID: 8013272
    [TBL] [Abstract][Full Text] [Related]  

  • 37. d-Propoxyphene kinetics after single oral and intravenous doses in man.
    Gram LF; Schou J; Way WL; Heltberg J; Bodin NO
    Clin Pharmacol Ther; 1979 Oct; 26(4):473-82. PubMed ID: 487695
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical pharmacologic observations on atenolol, a beta-adrenoceptor blocker.
    Brown HC; Carruthers SG; Johnston GD; Kelly JG; McAinsh J; McDevitt DG; Shanks RG
    Clin Pharmacol Ther; 1976 Nov; 20(5):524-34. PubMed ID: 10125
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intraperitoneal chemotherapy with melphalan.
    Howell SB; Pfeifle CE; Olshen RA
    Ann Intern Med; 1984 Jul; 101(1):14-8. PubMed ID: 6732077
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetics and bioavailability of viqualine, a new antidepressant.
    Fourtillan JB; Bouquet S; Girault J; Lefebvre MA; Maulet C; Courtois P
    Eur J Drug Metab Pharmacokinet; 1985; 10(1):3-10. PubMed ID: 4029218
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.